Follicular lymphoma is a cancer of the immune system.
Follicular lymphoma is a type of non-Hodgkin lymphoma, one of the most common forms of blood cancer. Non-Hodgkin lymphoma can be either fast growing (aggressive) or slow growing (indolent).
Follicular lymphoma is the most common slow-growing type and occurs in lymphocytes, a type of white blood cell. These cells are an important part of your immune system and help defend your body from infection.
When you have follicular lymphoma, too many white blood cells that are affected by the disease build up in your lymph nodes, blood, and bone marrow. They may also build up in your spleen (an organ in your immune system) and cause swelling of this organ.
Although individuals experience symptoms differently, those with follicular lymphoma often will notice an area of painless swelling on the body, such as on the neck, underarm, or groin. Since follicular lymphoma is slow-growing, immediate treatment is not always needed. If you don't appear to have symptoms, you may not be treated right away. This approach is called “active surveillance” or “watchful waiting.” When your doctor chooses this approach, he or she will closely monitor your condition.
You can take an active role in keeping an eye on your follicular lymphoma by paying careful attention to changes to your health and communicating symptoms to your doctor.
Possible follicular lymphoma symptoms you should watch for include (but are not limited to):
Your doctor may look for:
Follicular lymphoma cannot be diagnosed by symptoms alone. You are not often the first to notice your follicular lymphoma. It is usually detected by routine check-ups or blood work for other health issues.
If your doctor suspects follicular lymphoma after reviewing your signs and symptoms, he or she will order tests to confirm the diagnosis and to determine how advanced the disease is.
Explore questions you may want to ask your doctor.
Call our Patient Resource Center
This is not meant to replace the advice of your healthcare team.
You are leaving the GAZYVA® (obinutuzumab) site and connecting to a site that is under the shared control of Genentech, Inc. and AbbVie Inc, and may be governed by its own set of terms and conditions and privacy policy.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.